Veeva Systems IPO
Veeva Systems provides cloud-based software solutions specifically designed for the life sciences industry, including CRM, regulatory, and clinical trial management platforms. The company serves pharmaceutical, biotech, and medical device companies with specialized software that addresses industry-specific compliance and operational needs.
What We Know
Veeva Systems went public in October 2013 on the New York Stock Exchange under ticker VEEV, raising $289 million in its IPO. The company priced shares at $20 each and has been one of the most successful software IPOs of the past decade, with the stock appreciating significantly since going public. The company has consistently delivered strong financial performance as a public company, benefiting from the life sciences industry's digital transformation and increasing regulatory complexity. Veeva has expanded its product offerings and market presence substantially since its IPO, becoming a dominant player in life sciences software solutions.
Frequently Asked Questions
Has Veeva Systems had an IPO?
Yes, Veeva Systems completed its IPO in October 2013. The company has been publicly traded on the NYSE under ticker VEEV for over a decade.
When is the Veeva Systems IPO date?
Veeva Systems already completed its IPO on October 16, 2013. The company has been publicly traded for more than 10 years.
How can I buy Veeva Systems stock?
You can buy Veeva Systems stock through any brokerage account as it trades on the NYSE under ticker VEEV. The stock has been publicly available since 2013.
Don't Miss the Next Big IPO
Get notified when the next major company files for an IPO. Daily alerts delivered to your inbox.
Get IPO Alerts